Drug Prices: Effects of Opening Federal Supply Schedule for Pharmaceuticals Are Uncertain

GAO reviewed the factors that can affect negotiations for schedule drug prices and the potential effects of opening the pharmaceutical schedule on schedule prices available to federal, state, and local government purchasers. Although GAO reviewed economic and other assumptions used in these assessments, GAO did not validate the supporting data, such as drug prices and expenditures.